GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Third Harmonic Bio Inc (NAS:THRD) » Definitions » Price-to-Tangible-Book

Third Harmonic Bio (Third Harmonic Bio) Price-to-Tangible-Book : 1.74 (As of May. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Third Harmonic Bio Price-to-Tangible-Book?

As of today (2024-05-06), Third Harmonic Bio's share price is $11.70. Third Harmonic Bio's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $6.71. Hence, Third Harmonic Bio's Price to Tangible Book Ratio of today is 1.74.

The historical rank and industry rank for Third Harmonic Bio's Price-to-Tangible-Book or its related term are showing as below:

THRD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.59   Med: 1.11   Max: 1.74
Current: 1.74

During the past 4 years, Third Harmonic Bio's highest Price to Tangible Book Ratio was 1.74. The lowest was 0.59. And the median was 1.11.

THRD's Price-to-Tangible-Book is ranked better than
68.41% of 1222 companies
in the Biotechnology industry
Industry Median: 2.715 vs THRD: 1.74

A closely related ratio is called PB Ratio. As of today, Third Harmonic Bio's share price is $11.70. Third Harmonic Bio's Book Value per Sharefor the quarter that ended in Dec. 2023 was $6.71. Hence, Third Harmonic Bio's P/B Ratio of today is 1.74.


Third Harmonic Bio Price-to-Tangible-Book Historical Data

The historical data trend for Third Harmonic Bio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Third Harmonic Bio Price-to-Tangible-Book Chart

Third Harmonic Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - 0.59 1.63

Third Harmonic Bio Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.58 0.70 0.93 1.63

Competitive Comparison of Third Harmonic Bio's Price-to-Tangible-Book

For the Biotechnology subindustry, Third Harmonic Bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Third Harmonic Bio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Third Harmonic Bio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Third Harmonic Bio's Price-to-Tangible-Book falls into.



Third Harmonic Bio Price-to-Tangible-Book Calculation

Third Harmonic Bio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=11.70/6.71
=1.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Third Harmonic Bio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Third Harmonic Bio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Third Harmonic Bio (Third Harmonic Bio) Business Description

Traded in Other Exchanges
N/A
Address
1700 Montgomery Street, Suite 210, San Francisco, CA, USA, 94111
Third Harmonic Bio Inc is a clinical-stage company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases.. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival.
Executives
Julie Person officer: Chief Administrative Officer C/O THIRD HARMONIC BIO, INC., 300 TECHNOLOGY SQUARE, 8TH FLOOR, CAMBRIDGE MA 02139
Edward R. Conner officer: Chief Medical Officer 501 CANAL BLVD., POINT RICHMOND TECH CENTER, RICHMOND CA 94804
Biotechnology Value Fund L P other: See Explanation of Responses 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Partners L P/il 10 percent owner 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Gp Holdings Llc other: See Explanation of Responses 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Ii Gp Llc other: See Explanation of Responses 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf I Gp Llc other: See Explanation of Responses 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Partners Os Ltd. other: See Explanation of Responses P.O. BOX 309 UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Biotechnology Value Trading Fund Os Lp other: See Explanation of Responses P.O. BOX 309 UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Bvf Inc/il 10 percent owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Mark N Lampert 10 percent owner 1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104
Biotechnology Value Fund Ii Lp other: See Explanation of Responses 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Orbimed Advisors Llc director, 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
David P Bonita director, 10 percent owner C/O ORBIMED ADVISORS LLC, 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Atlas Venture Fund Xi, L.p. 10 percent owner 400 TECHNOLOGY SQUARE, 10TH FLOOR, CAMBRIDGE MA 02139